Cargando…

Comparative Effectiveness Review of Antiplatelet Agents in Peripheral Artery Disease

Detalles Bibliográficos
Autores principales:	Schmit, Kristine, Dolor, Rowena J., Jones, W. Schuyler, Vemulapalli, Sreekanth, Hasselblad, Victor, Subherwal, Sumeet, Heidenfelder, Brooke, Patel, Manesh R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338727/ https://www.ncbi.nlm.nih.gov/pubmed/25477329 http://dx.doi.org/10.1161/JAHA.113.001330

Ejemplares similares

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review
por: Sherwood, Matthew W., et al.
Publicado: (2015)

Lower extremity amputation in peripheral artery disease: improving patient outcomes
por: Swaminathan, Aparna, et al.
Publicado: (2014)

A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response
por: Loungani, Rahul S., et al.
Publicado: (2020)

Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials?
por: Vemulapalli, Sreekanth, et al.
Publicado: (2018)

National trends in repair for type B aortic dissection
por: Weissler, E. Hope, et al.
Publicado: (2021)

Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
por: Matli, Kamal, et al.
Publicado: (2021)

Implications of direct oral anticoagulation and antiplatelet therapy in intensive care
por: Willcox, Abbey, et al.
Publicado: (2023)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Integrating dissemination and implementation sciences within Clinical and Translational Science Award programs to advance translational research: Recommendations to national and local leaders
por: Mehta, Tara G., et al.
Publicado: (2021)

The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease
por: Tsai, Thomas T., et al.
Publicado: (2015)

A Meta-Analysis of Randomized Controlled Trials on Antiplatelet Agents Versus Placebo/Control for Treating Peripheral Artery Disease
por: Qian, Jun, et al.
Publicado: (2015)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial
por: Norgren, Lars, et al.
Publicado: (2021)

Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease
por: Szarek, Michael, et al.
Publicado: (2022)

Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
por: Swaminathan, Rajesh V., et al.
Publicado: (2019)

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
por: Matli, Kamal, et al.
Publicado: (2021)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Patterns of antiplatelet agent use in the US
por: Kanakadandi, Vijay, et al.
Publicado: (2015)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries
por: Kronlage, Mariya, et al.
Publicado: (2017)

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID
por: Samsky, Marc D., et al.
Publicado: (2021)

New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013)

Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON)
por: Higashi, Yukihito, et al.
Publicado: (2017)

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study
por: Kremers, B. M. M., et al.
Publicado: (2023)

Newer agents in antiplatelet therapy: a review
por: Yeung, Jennifer, et al.
Publicado: (2012)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Situating dissemination and implementation sciences within and across the translational research spectrum
por: Leppin, Aaron L., et al.
Publicado: (2019)

Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
por: Galani, Jemi, et al.
Publicado: (2021)

Peripheral interventions and antiplatelet therapy: Role in current practice
por: Singh, Pahul, et al.
Publicado: (2017)

Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials
por: Tang, Tao, et al.
Publicado: (2021)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Model-Based Algorithms for Detecting Peripheral Artery Disease Using Administrative Data From an Electronic Health Record Data System: Algorithm Development Study
por: Weissler, Elizabeth Hope, et al.
Publicado: (2020)

THE IMPACT OF THE COVID19 PANDEMIC ON PATIENTS WITH PERIPHERAL ARTERY DISEASE
por: Tanaka, John, et al.
Publicado: (2023)

Emerging antiplatelet agents, differential pharmacology, and clinical utility
por: Das, Pranab, et al.
Publicado: (2010)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qi2r8s6eeuoq9hbop210lq3d67